EXCLUSIVE: Pro-Turkey Lobbyist Sought Secret

New Post Public Reply Private Reply Replies (2) Message Board
SaltyMutt




EXCLUSIVE: Pro-Turkey Lobbyist Sought Secret Favors From Hillary And Huma

Newly released emails show that a former Democratic National Committee official and lobbyist for the Turkish government directly contacted two of Hillary Clinton’s top aides to ask for a favor ahead of the then-secretary of state’s March 2009 visit to Turkey.

The correspondence raises numerous questions because the lobbyist, David Mercer, was paid $25,000 a month by the Turkish government to convince lawmakers and government officials to oppose a bill designating the Ottoman Empire’s murder of an estimated 1.5 million Armenian Orthodox Christians from 1915 to 1917 a genocide.

Clinton once touted her support for the resolution but flip-flopped dramatically after she joined the Obama administration.

Mercer, who once served as deputy national finance director for the DNC, also appears to have failed to disclose the contact with the two Clinton aides — her deputy chief of staff Huma Abedin and Capricia Penavic Marshall, then an operative for one of Clinton’s campaign committees — under the Foreign Agents Registration Act (FARA).

The emails, which are entitled “Key Contact” and which the State Department recently turned over to the watchdog group Judicial Watch, offer a rare glimpse at a lobbyist comfortable enough with a Clinton insider to boldly ask for political favors.

“Hi Huma — Hope all’s well and you’re having a successful trip. Could you please make contact with [redacted]? I greatly appreciate it. If you need additional information don’t hesitate to email me or reach me by cell at [redacted],” Mercer wrote to Abedin on March 4, just days ahead of Clinton’s first visit to Turkey as secretary of state.
While in Turkey Clinton met with then-President Abdullah Gul, then-Prime Minister Recep Tayyip Erdogan, and Foreign Minister Ali Babacan. In her public remarks she touted the two countries’ NATO alliance and partnership in fighting terrorism.

The U.S.’s reliance on the relatively moderate Islamic regime in the fight against terror helps explain administrations past and present have been hesitant to label the mass slaughter of Armenians a genocide. Turkey strongly opposes the resolution and has threatened economic and diplomatic retaliation if one is passed.

Mercer is one of the chief players in a powerful network of lobbyists that the Turkish government has paid millions of dollars to help communicate the country’s position on the issue.

Described as a protege to Bill Clinton Sec. of Commerce Ron Brown, Mercer was sub-contracted through the Beltway lobbying firm DLA Piper to handle the $25,000-per-month Turkish lobbying effort. One DLA Piper lobbyist who also worked the account was former House Speaker Richard Gephardt, a Missouri Democrat.

In 2008, DLA Piper was the second biggest corporate contributor to Clinton’s campaign, according to the Center for Responsive Politics. It is listed as the eight largest Clinton donor of the 2016 cycle.

Mercer’s email to Marshall, who at the time worked for the pro-Clinton campaign committee, Friends of Hillary, suggests that the longtime Clinton insider had already moved to help the lobbyist.

“Here’s the email I sent to Huma regarding [redacted]. Thanks very much for your help in all this. It would be great if Huma gave [redacted] a call prior to their arrival in Turkey which I believe is tomorrow,” he wrote to Marshall on March 6.

That August, Marshall would take a job as State’s chief protocol officer. In that role she was in charge of accommodating foreign dignitaries. She received her last paycheck from Friends of Hillary on July 31, 2009, federal records show.

Mercer donated a total of $10,000 to Clinton’s various campaigns, including Friends of Hillary, according to federal records.

Marshall emailed Abedin, who is Muslim, minutes after receiving Mercer’s message.

“On this matter — David called me again and I asked [redacted] to talk to [redacted] and this is what she learned,” she wrote.

It is not entirely clear what the trio discussed in the emails because the State Department redacted portions of the records under an exemption category reserved for attorney-client privilege and the “deliberative process.”

But the messages were sent and received at a crucial inflection point for Clinton on the Armenian genocide issue.

As a New York senator, Clinton supported several resolutions calling for the recognition of the mass murders as genocide. And as a Democratic presidential candidate in 2008 she issued a statement promising to recognize the genocide if elected president. She said then that “alone among the presidential candidates, I have been a long-standing supporter of the Armenian Genocide Resolution.”

The pledge earned Clinton the praise of the Armenian National Committee of America (ANCA), the largest Armenian political organization in the U.S.

But Clinton completely reversed course on the issue and refused to use the “g-word” to describe the century-old atrocity after she entered the Obama administration.

During a State Department town hall in Jan. 2012 she said that the issue of whether the mass murder was genocide was still up for debate.

“I think it’s fair to say that this has always been viewed, and I think properly so, as a matter of historical debate and conclusions rather than political,” she said at the time.

Clinton was called out for the comments in a House Appropriations Subcommittee hearing the next month by California Rep. Adam Schiff ?14%, who is currently a member of the House Select Benghazi Committee and one of Clinton’s most ardent supporters.

“Some actions that were taken by you and the administration with regard to the Armenian genocide which are of great concern,” he said during the hearing.

“I can’t begin to express in mere words how much anguish has been caused in the Armenian-American community and among many activists about recent statements at a State Department town hall that you made,” he added.

Clinton flailed as she attempted to defend downplaying her statement that the Armenian genocide was still up for debate.

Aram Suren Hamparian, who once praised Clinton as ANCA’s executive director, had harsh words for both Mercer and Clinton.

“Mr. Mercer profited personally by aiding and abetting Turkey’s shameful cover up of its genocide of millions of Armenians, Greeks, Assyrians and other Christians. Mr. Mercer’s complicity in Ankara’s genocide denial represents an unconscionable corruption of U.S. democracy by high-priced lobbyists, a morally unacceptable compromise of American values by a foreign power,” Hamparian told The Daily Caller.

Mercer has disclosed other contacts with politicians and government officials in other FARA filings, including a Dec. 2008 letter to Abedin.

But he did not respond by press time to a request for comment on the contents of the emails he sent and why they were not revealed in Foreign Agents Registration Act (FARA) disclosures. The powerbroker filed the reports on March 26, 2009 even though he started lobbying for Turkey in 2007.

It is likely that Clinton and company were aware of Mercer’s role as an opponent of the Armenian resolution. FARA records show that he sent letters to Lee Feinstein, the national security director of Clinton’s campaign, at around the time she publicly supported the genocide resolution.

“Hillary Clinton needs to answer for her morally indefensible actions as Secretary of State enforcing Turkey’s gag-rule against American condemnation and commemoration of the Armenian Genocide,” Hamparian told TheDC.

Clinton has not weighed in on the genocide issue during the 2016 cycle. Her campaign did not respond to TheDC’s request for comment.

This article has been updated with additional information.


Read more: http://dailycaller.com/2016/05/17/exclusive-p...z496NEpwQb
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infosys Pushes AI Growth with Strong Deal Wins

Updated Category News Views 17

Riding the AI Wave Who knew Infosys was a lightning rod for AI momentum, eh? With a 29% quarterly surge in AI revenue, the firm's really putting AI strategy at center stage. Considering today's finicky markets, that's not just peanuts. CEO Salil Parekh's swagger is backed by real numbers, seeing AI revenue inch to 10.5% of total haul. This ain't just talk—Infosys is...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 37

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 36

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 30

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 15

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading
BOB Raises $5.5M for AI Banking Platform Revolution

Updated Category News Views 24

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Continue Reading
GeeLark's Tech Leap: Expanding Cloud Phone Functions

Updated Category News Views 3

GeeLark's New Frontier GeeLark is kicking up some dust in the tech space by tooling up its cloud phone workflows with an arsenal of new supports: API, CLI, and MCP. This isn't just some minor patch, folks. It's a bold move, and for those in the quicksand of digital operations, a game-changer. You know how much of a drag it is repeating the same setup steps over and over?...

Continue Reading

Top 5 Most Recently Viewed Articles

CoinW Showcases Its Innovations at Taipei Blockchain Week 2024

Updated Category News Views 261

CoinW's Impactful Presence at Taipei Blockchain Week 2024 At the forefront of innovation and security, CoinW, a globally recognized cryptocurrency exchange, recently showcased its vision for the future during Taipei Blockchain Week 2024 as a Gold Sponsor. The event, celebrated for fostering discussions on blockchain advancements, featured the launch of PropW, CoinW's...

Continue Reading
Bank of Åland Plc Seeks Trading Admission of New Covered Bonds

Updated Category News Views 170

Application for Trading Admission of Covered Bonds Bank of Åland Plc, also recognized as Ålandsbanken Abp, is taking an important step by applying for the admission of a new security to trading on Nasdaq Helsinki. This involves their recent issuance of covered bonds, which are highly regarded in the financial market. Details of the Covered Bonds Issue The primary...

Continue Reading
Simpson Manufacturing's Q3 Earnings Report Shows Challenges Ahead

Updated Category News Views 54

Simpson Manufacturing's Third Quarter Performance Simpson Manufacturing Co., Inc. (NYSE: SSD) recently announced its third-quarter earnings, and the results did not meet the expectations of analysts. This disappointing performance resulted in a 5% decline in shares during after-hours trading. The company's focus on producing wood construction products highlights the...

Continue Reading
Alvotech Faces Challenges in Biologics License Approval Process

Updated Category News Views 349

Overview of Biologics License Application Status Alvotech, a prominent biotech firm specializing in biosimilars, has recently updated the market regarding its application status for AVT05, a potential competitor to Simponi (golimumab). The company has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) highlighting certain...

Continue Reading
Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 127

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading